Side Effects & Safety Mild GI discomfort most common, usually transient in the first week Slight stimulant effect increased energy/alertness, especially early on Headaches occasional, typically mild and dose-related Mild insomnia if taken too late in the day No human clinical safety data all safety information from preclinical studies and community reports No liver toxicity observed in animal studies at therapeutic doses Unknown drug interactions theoretically could interact with NAD+-dependent pathways Core Supplies for This Protocol The three essentials for running any reconstituted injectable: cold storage, accurate syringes, and metabolic tracking
Take three measurements and average them
No Rebound Hunger or Metabolic Adaptation Appetite suppressants that work through central mechanisms (GLP-1 agonists, sympathomimetics, serotonergic agents) typically create tolerance over time, requiring dose escalation, and often produce rebound hunger when discontinued
5-Amino-1MQ doesn't act on appetite, it works by inhibiting NNMT, which shifts cell metabolism toward fat oxidation and muscle preservation
Now you're looking at peptides
Administered through various routes such as injections, oral ingestion, and topical applications, therapeutic peptides have shown remarkable efficacy in reducing inflammation, improving wound healing, and enhancing physical activity
